340 related articles for article (PubMed ID: 25043692)
1. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
[TBL] [Abstract][Full Text] [Related]
3. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
[TBL] [Abstract][Full Text] [Related]
4. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
5. Oxysterol-induced soluble endoglin release and its involvement in hypertension.
Valbuena-Diez AC; Blanco FJ; Oujo B; Langa C; Gonzalez-Nuñez M; Llano E; Pendas AM; Díaz M; Castrillo A; Lopez-Novoa JM; Bernabeu C
Circulation; 2012 Nov; 126(22):2612-24. PubMed ID: 23110859
[TBL] [Abstract][Full Text] [Related]
6. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
[TBL] [Abstract][Full Text] [Related]
7. Transcription factors E2F1 and E2F3 are expressed in placenta but do not regulate MMP14.
Kaitu'u-Lino TJ; Hastie R; Cannon P; Nguyen H; Lee S; Hannan NJ; Tong S
Placenta; 2015 Aug; 36(8):932-7. PubMed ID: 26145228
[TBL] [Abstract][Full Text] [Related]
8. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
9. Loss of Akt increases soluble endoglin release from endothelial cells but not placenta.
Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Brownfoot F; De Silva M; Cannon P; Tuohey L; Tong S
Pregnancy Hypertens; 2016 Apr; 6(2):95-102. PubMed ID: 27155335
[TBL] [Abstract][Full Text] [Related]
10. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
[TBL] [Abstract][Full Text] [Related]
11. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
[TBL] [Abstract][Full Text] [Related]
12. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
[TBL] [Abstract][Full Text] [Related]
14. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
[TBL] [Abstract][Full Text] [Related]
15. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
16. Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
Hastie R; Ye L; Hannan NJ; Brownfoot FC; Cannon P; Nguyen V; Tong S; Kaitu'u-Lino TJ
Pregnancy Hypertens; 2018 Oct; 14():125-130. PubMed ID: 30527099
[TBL] [Abstract][Full Text] [Related]
17. MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin.
Kaitu'u-Lino TJ; Palmer K; Tuohey L; Ye L; Tong S
PLoS One; 2012; 7(6):e39864. PubMed ID: 22768148
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells.
Tskitishvili E; Sharentuya N; Temma-Asano K; Mimura K; Kinugasa-Taniguchi Y; Kanagawa T; Fukuda H; Kimura T; Tomimatsu T; Shimoya K
Mol Hum Reprod; 2010 Mar; 16(3):188-99. PubMed ID: 19939849
[TBL] [Abstract][Full Text] [Related]
19. Gadd45α as an upstream signaling molecule of p38 MAPK triggers oxidative stress-induced sFlt-1 and sEng upregulation in preeclampsia.
Luo X; Yao ZW; Qi HB; Liu DD; Chen GQ; Huang S; Li QS
Cell Tissue Res; 2011 Jun; 344(3):551-65. PubMed ID: 21519896
[TBL] [Abstract][Full Text] [Related]
20. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.
Hannan NJ; Binder NK; Beard S; Nguyen TV; Kaitu'u-Lino TJ; Tong S
PLoS One; 2018; 13(4):e0187082. PubMed ID: 29641523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
